US 10544111
Heterocyclic compound
granted A61KA61K31/415A61K31/421
Quick answer
US patent 10544111 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K31/415, A61K31/421, A61K31/4418, A61K31/505